Here, we confirmed a trend toward higher expression of PD-L1 proteins in lung cancer cell lines sensitive to EGFR inhibitors, and demonstrated for the first time that the expression of PD-L1 can be further up-regulated in the presence of IFNγ especially in lung cancer cell lines sensitive to EGFR inhibitors. This evidence concerns the gene EGFR and lung carcinoma.